Transcription factor PITX3 gene in Parkinson's disease

Neurobiology of Aging

Volumn 32, Issue 4, 2011, Pages 750-753

  Le, Weidong ^a   Nguyen, Deanne ^a   Lin, Xiyao Wendy ^a   Rawal, Pawan ^a   Huang, Maosheng ^b   Ding, Yujian ^c   Xie, Wenjie ^a   Deng, Hao ^d   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dopaminergic neurons; Neurogenetics; Single nucleotide polymorphisms; Substantia nigra

Indexed keywords

ADENINE; CYTOSINE; THYMINE; TRANSCRIPTION FACTOR PITX3;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; GENE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PARKINSON DISEASE; PITX3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY;

ALLELES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; MALE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 79953049313     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.03.015     Document Type: Article

References (15)

1. Alavian K.N., Scholz C., Simon H.H. Transcription regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov. Dis. 2008, 23(3):319-328.
2. Ardayfio P., Moon J., Leung K.K., Youn-Hwang D., Kim K.S. Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease. Neurobiol. Dis. 2008, 31(3):406-412.
3. Bergman, O., Hakansson, A., Westberg, L., Nordenstrom, K., Belin, A.C., Sydow, O., Olson, L., Holmberg, B., Eriksson, E., Nissbrandt, H., 2008. PITX3 polymorphism is associated with early onset Parkinson's disease. Neurobiol. Aging 2008 April 15 [Epub ahead of print].
4. Deng H., Le W.D., Zhang X., Pan T.H., Jankovic J. G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients. Acta Neurol. Scand. 2005, 111(6):351-352.
5. Fuchs, J., Mueller, J.C., Lichtner, P., Schulte, C., Munz, M., Berg, D., Wüllner, U., Illig, T., Sharma, M., Gasser, T., 2007. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol. Aging 2007 September 28 [Epub ahead of print].
6. Jacobs F.M., Smits S.M., Noorlander C.W., et al. Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 2007, 134(14):2673-2684.
7. Jankovic J., Chen S., Le W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Progr. Neurobiol. 2005, 77:128-138.
8. Jankovic J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
9. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
10. Komar A.A. Genetics. SNPs, silent but not invisible. Science 2007, 315(5811):466-467.
11. Le W., Chen S., Jankovic J. Etiopathogenesis of Parkinson's disease: a new beginning?. Neuroscientist 2009, 15:28-35.
12. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. PNAS 2003, 100:4245-4250.
13. Peng C., Fan S., Li X., Fan X., Ming M., Sun Z., Le W. Overexpression of pitx3 upregulates expression of BDNF and GDNF in SH-SY5Y cells and primary ventral mesencephalic cultures. FEBS 2007, 581(7):1357-1366.
14. Smidt M.P., Smits S.M., Bouwmeester H., Hamers F.P., van der Linden A.J., Hellemons A.J., Graw J., Burbach J.P. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 2004, 131(5):1145-1155.
15. Thi Tran H.T., Takeshima Y., Surono A., Yagi M., Wada H., Matsuo M. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro. Mol. Genet. Metab. 2005, 85(3):213-219.